These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 8144401

  • 21. A phase II study of carboplatin as a treatment for children with acute leukemia recurring in bone marrow: a report of the Children's Cancer Group.
    Ettinger LJ, Ivy P, Gaynon PS, Ettinger AG, Liu-Mares W, Krailo MD.
    Cancer; 1997 Jul 15; 80(2):311-6. PubMed ID: 9217045
    [Abstract] [Full Text] [Related]

  • 22. Timed sequential therapy of acute leukemia with flavopiridol: in vitro model for a phase I clinical trial.
    Karp JE, Ross DD, Yang W, Tidwell ML, Wei Y, Greer J, Mann DL, Nakanishi T, Wright JJ, Colevas AD.
    Clin Cancer Res; 2003 Jan 15; 9(1):307-15. PubMed ID: 12538483
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Siderophilic erythrokaryocytes of the bone marrow at various periods during the course of acute leukemia].
    Vorob'ev VG.
    Gematol Transfuziol; 1989 May 15; 34(5):8-12. PubMed ID: 2744393
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Post chemotherapy blood and bone marrow regenerative changes in childhood acute lymphoblastic leukemia a prospective study.
    Kushwaha R, Kumar A, Aggrawal K, Nigam N, Kumar A.
    Indian J Pathol Microbiol; 2014 May 15; 57(1):72-7. PubMed ID: 24739836
    [Abstract] [Full Text] [Related]

  • 27. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
    Liu YL, Wang XN, Liu HS.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun 15; 22(3):629-33. PubMed ID: 24989266
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Blast cell proliferative activity and sensitivity to GM-CSF in vitro are associated with early response to TAD-9 induction therapy in acute myeloid leukemia.
    Jahns-Streubel G, Reuter C, Unterhalt M, Schleyer E, Wörmann B, Büchner T, Hiddemann W.
    Leukemia; 1995 Nov 15; 9(11):1857-63. PubMed ID: 7475275
    [Abstract] [Full Text] [Related]

  • 34. Use of alpha-2a-interferon to treat cytogenetic relapse of chronic myeloid leukemia after marrow transplantation.
    Higano CS, Chielens D, Raskind W, Bryant E, Flowers ME, Radich J, Clift R, Appelbaum F.
    Blood; 1997 Oct 01; 90(7):2549-54. PubMed ID: 9326220
    [Abstract] [Full Text] [Related]

  • 35. Cell proliferation in childhood acute leukemia. Comparison of Ki-67 and proliferating cell nuclear antigen immunocytochemical and DNA flow cytometric analysis.
    Ito M, Tsurusawa M, Zha Z, Kawai S, Takasaki Y, Fujimoto T.
    Cancer; 1992 Apr 15; 69(8):2176-82. PubMed ID: 1347483
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.